Core Laboratories Inc. CLB
8.87 USD -0.06 (-0.66%)
Nov 6, 2026, 2:21 PM EST
8.82 Day range 8.97
8.75 52-week range 20.36
- YTD
- -44.66%
- 1 year
- -41.98%
News
zacks.com CLB Q3 Earnings Miss Estimates on Higher Costs and Disruptions Core Laboratories' Q3 earnings missed estimates amid rising costs and geopolitical disruptions, despite a revenue beat and stronger international lab activity.
marketbeat.com Core Laboratories Q3 Earnings Call Highlights Core Laboratories NYSE: CLB reported higher third-quarter revenue, operating income and earnings per share from the prior quarter, while geopolitical disruptions in the Middle East and Russia-Ukraine…
benzinga.com Core Laboratories Q3 Adj. EPS $0.16, Inline, Sales $132.077M Miss $132.143M Estimate Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 27.27 percent decrease over earnings of $0.22 per share from the same…
benzinga.com Core Laboratories Sees Q4 GAAP EPS $0.12-$0.20 vs $0.17 Est; Sees Sales $128.500M-$134.500M vs $133.317M Est Core Laboratories (NYSE:CLB) is looking for Q4 GAAP EPS of $0.12-$0.20 vs $0.17 analyst estimate. sees sales of $128.500 million-$134.500 million vs $133.317 million analyst estimate.
benzinga.com Top 3 Energy Stocks You'll Regret Missing In September Oversold energy stocks may offer buying opportunities, with Baker Hughes, CNX Resources and Core Laboratories showing RSI readings below 30.- benzinga.com Core Laboratories Q2 Adj. EPS $0.11 Beats $0.09 Estimate, Sales $124.609M Miss $125.100M Estimate Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. This is a 42.11 percent decrease over earnings of…
benzinga.com Core Laboratories Sees Q3 GAAP EPS $0.12-$0.20 vs $0.16 Est; Sees Sales $128.500M-$135.500M vs $131.330M Est Core Laboratories (NYSE:CLB) is looking for Q3 GAAP EPS of $0.12-$0.20 vs $0.16 analyst estimate. sees sales of $128.500 million-$135.500 million vs $131.330 million analyst estimate.
benzinga.com Mobility Global To Replace Core Laboratories Effective Prior To The Opening Of Trading On Thursday, July 2 https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20260626-1484136/1484136_spgi-sem-5-6.pdf
benzinga.com Top 3 Energy Stocks That May Jump In Q2 Opportunity to buy undervalued energy stocks as RSI shows oversold levels. NCS Multistage, Core Laboratories, and Transportadora de Gas del Sur SA are major players with RSI near or below 30.
benzinga.com Core Laboratories Sees Q2 GAAP EPS $0.06-$0.12 vs $0.09 Est; Sees Sales $123.000M-$131.000M vs $127.900M Est Core Laboratories (NYSE:CLB) is looking for Q2 GAAP EPS of $0.06-$0.12 vs $0.09 analyst estimate. sees sales of $123.000 million-$131.000 million vs $127.900 million analyst estimate.- benzinga.com Core Laboratories Q1 Adj. EPS $0.06 Misses $0.11 Estimate, Sales $121.797M Miss $124.935M Estimate Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.11 by 45.45 percent. This is a 57.14 percent decrease over earnings of…
benzinga.com Earnings Scheduled For April 29, 2026 
benzinga.com Core Laboratories Sees Q1 Adj EPS $0.05-$0.07 vs $0.14 Est; Lowers Q1 Sales Guidance from $124.000M-$130.000M to $119.000M-$123.000M vs $128.290M Est Core Laboratories (NYSE:CLB) is looking for Q1 Adj EPS of $0.05-$0.07 vs $0.14 analyst estimate. Lowers Q1 sales outlook from $124.000 million-$130.000 million to $119.000 million-$123.000 million vs…- benzinga.com Core Laboratories Sees Q1 GAAP EPS $0.11-$0.15 vs $0.15 Est; Sees Sales $124.000M-$130.000M vs $128.290M Est Core Laboratories (NYSE:CLB) is looking for Q1 GAAP EPS of $0.11-$0.15 vs $0.15 analyst estimate. sees sales of $124.000 million-$130.000 million vs $128.290 million analyst estimate.
- benzinga.com Core Laboratories Q4 Adj. EPS $0.21 Beats $0.19 Estimate, Sales $138.255M Beat $131.100M Estimate Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.19 by 11.11 percent. This is a 4.55 percent decrease over earnings of $0.22…
- benzinga.com Earnings Scheduled For February 4, 2026
benzinga.com P/E Ratio Insights for Core Laboratories 
benzinga.com Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Big Stocks Moving Higher On Thursday 
benzinga.com Earnings Scheduled For October 22, 2025 
benzinga.com A Preview Of Core Laboratories's Earnings 
benzinga.com Earnings Scheduled For July 23, 2025 - benzinga.com Core Laboratories's Earnings Outlook
- benzinga.com Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $12 Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $13 to $12.
- benzinga.com Citigroup Maintains Neutral on Core Laboratories, Lowers Price Target to $13 Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Neutral and lowers the price target from $16 to $13.
- benzinga.com Core Laboratories Sees Q2 GAAP EPS $0.17-$0.21 vs $0.24 Est; Sees Sales $128.000M-$134.000M vs $136.01M Est Core Laboratories (NYSE:CLB) is looking for Q2 GAAP EPS of $0.17-$0.21 vs $0.24 analyst estimate. sees sales of $128.000 million-$134.000 million vs $136.01 million analyst estimate.
- benzinga.com Core Laboratories Q1 Adj. EPS $0.14 Misses $0.19 Estimate, Sales $123.58M Miss $129.80M Estimate Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.19 by 26.32 percent. This is a 26.32 percent decrease over earnings of…
benzinga.com Earnings Scheduled For April 23, 2025 - benzinga.com Examining the Future: Core Laboratories's Earnings Outlook
- benzinga.com Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $15 Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $19 to $15.
benzinga.com Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday - benzinga.com Citigroup Upgrades Core Laboratories to Neutral, Raises Price Target to $16 Citigroup analyst Scott Gruber upgrades Core Laboratories (NYSE:CLB) from Sell to Neutral and raises the price target from $15 to $16.
- benzinga.com Citigroup Maintains Sell on Core Laboratories, Raises Price Target to $15 Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and raises the price target from $14 to $15.
- benzinga.com Core Laboratories Q4 2024 Adj EPS $0.22, Inline, Sales $129.24M Miss $132.44M Estimate Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.22 per share which met the analyst consensus estimate. This is a 15.79 percent increase over earnings of $0.19 per share from the same…
- benzinga.com Insights into Core Laboratories Q4 Earnings
- benzinga.com Earnings Scheduled For January 29, 2025
- benzinga.com Arm Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- benzinga.com Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket Shares of Rumble Inc.
- benzinga.com Citigroup Maintains Sell on Core Laboratories, Lowers Price Target to $14 Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and lowers the price target from $15 to $14.
- benzinga.com Core Laboratories Q3 2024 Adj EPS $0.25 Beats $0.23 Estimate, Sales $134.40M Miss $134.46M Estimate Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.23 by 8.7 percent. The company reported quarterly sales of $134.40 million…
- benzinga.com Stifel Maintains Hold on Core Laboratories, Raises Price Target to $22 Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and raises the price target from $18 to $22.
- benzinga.com Core Laboratories Q2 2024 Adj EPS $0.22 Beats $0.21 Estimate, Sales $130.577M Miss $132.170M Estimate Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.21 by 4.76 percent. This is a 4.76 percent increase over earnings of $0.21…
- benzinga.com B of A Securities Maintains Underperform on Core Laboratories, Lowers Price Target to $15 B of A Securities analyst Chase Mulvehill maintains Core Laboratories (NYSE:CLB) with a Underperform and lowers the price target from $16 to $15.
- benzinga.com Piper Sandler Maintains Neutral on Core Laboratories, Lowers Price Target to $17 Piper Sandler analyst Luke Lemoine maintains Core Laboratories (NYSE:CLB) with a Neutral and lowers the price target from $18 to $17.
- benzinga.com Stifel Maintains Hold on Core Laboratories, Raises Price Target to $18 Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and raises the price target from $17 to $18.
- benzinga.com Earnings Scheduled For January 31, 2024 Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.
- benzinga.com Earnings Scheduled For November 1, 2023 Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
- benzinga.com Earnings Scheduled For July 26, 2023 Companies Reporting Before The Bell • GSK (NYSE:GSK) is estimated to report quarterly earnings at $0.87 per share on revenue of $8.97 billion. • Stellantis (NYSE:STLA) is likely to report earnings…
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023
- benzinga.com Nasdaq, Methanex And Other Big Stocks Moving Lower On Monday U.S. stocks traded higher, with the Nasdaq Composite rising around 70 points on Monday. Here are some big stocks recording losses in today’s session. Beneficient (NASDAQ: BENF) shares fell 17% to…
- benzinga.com Earnings Scheduled For April 26, 2023 Companies Reporting Before The Bell • Teck Resources (NYSE:TECK) is expected to report quarterly earnings at $1.36 per share on revenue of $3.11 billion.